HNN3.0
Register
Register
Register

Project cooperationUpdated on 23 January 2026

Remote patient monitoring of physical resilience

Project Manager / Product Owner at Eforto

Oudsbergen, Belgium

About

Eforto is a unique solution to measure and track physical resilience and vitality capacity based on WHO recommended biomarkers, muscle strength, muscle endurance (performance fatigue) and self perceived fatigue.

It has been validated to detect sub clinical frailty, but we see many other applications since we our digital biomarkers are not only measuring the neuro-muscular function but also energy metabolism, inflammation and stress response of the body

  • Muscle quality (strength, power and endurance) assessment and remote monitoring

  • Frailty and fall prevention screening via a (self)-test

  • Screening and tracking of burnout and resilience

  • Peri-operative risk stratification for major surgery and oncology

  • Disease progress and response in neurodegenerative and neuromuscular diseases

  • (Remote) monitoring of all domains of intrinsic capacity: locomotor capacity, cognitive capacity, psychologic capacity, and vitality capacity

  • Tracking effects of interventions like nutrition, physical activity, exercise, stress management, sleep, metal and cognitive coaching

  • Healthy ageing and intrinsic capacity

  • Tracking of metabolic performance and inflammation via non invasive biomarkers

We have vast experience with EU grant projects
We are open to joining consortia as:

  • a technology development partner,

  • a pilot / demonstration case, or

  • a work package leader for device innovation, for remote monitoring.

    Reach out for more details or feel free to schedule a call at your convenience using my online agenda: https://calendar.app.google/eVZGxv3rXn2grduaA

I look forward to connecting with you soon.

Type

  • Partner seeks Consortium/Coordinator

Organisation

Eforto

Company (SME)

Meise, Belgium

Similar opportunities

  • Project cooperation

    Remote patient monitoring of physical resilience

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Rudi Tielemans

    CEO & Founder at Eforto

    Brussels, Belgium

  • Project cooperation

    Stress relief 4 students

    • Partner seeks Consortium/Coordinator

    Valentina Agostini

    Associate professor in Biomedical Engineering at Politecnico di Torino

    Torino, Italy

  • Project cooperation

    Health projects at Eurecat

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults

    MARTA SANS VALLS

    European Programme Manager at Fundacio Eurecat

    Barcelona, Spain